Sentry Investment Management LLC Has $94,000 Position in The Clorox Company (NYSE:CLX)

Sentry Investment Management LLC decreased its stake in The Clorox Company (NYSE:CLXFree Report) by 10.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 720 shares of the company’s stock after selling 80 shares during the period. Sentry Investment Management LLC’s holdings in Clorox were worth $94,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its position in shares of Clorox by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 14,685,046 shares of the company’s stock valued at $2,041,661,000 after purchasing an additional 185,012 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Clorox by 4.9% in the second quarter. BlackRock Inc. now owns 9,929,208 shares of the company’s stock worth $1,579,141,000 after buying an additional 466,197 shares during the period. Geode Capital Management LLC boosted its position in Clorox by 3.4% during the 2nd quarter. Geode Capital Management LLC now owns 2,818,428 shares of the company’s stock valued at $447,149,000 after acquiring an additional 93,018 shares in the last quarter. Northern Trust Corp boosted its position in shares of Clorox by 1.1% in the 1st quarter. Northern Trust Corp now owns 1,931,351 shares of the company’s stock worth $268,515,000 after purchasing an additional 21,058 shares in the last quarter. Finally, Morgan Stanley raised its stake in Clorox by 7.1% during the 4th quarter. Morgan Stanley now owns 1,800,576 shares of the company’s stock valued at $252,675,000 after buying an additional 119,164 shares during the last quarter. Institutional investors and hedge funds own 77.98% of the company’s stock.

Wall Street Analyst Weigh In

CLX has been the subject of a number of analyst reports. Sanford C. Bernstein upgraded Clorox from an “underperform” rating to a “market perform” rating and set a $120.00 price target for the company in a research note on Thursday, October 12th. Jefferies Financial Group assumed coverage on shares of Clorox in a report on Monday, November 13th. They set an “underperform” rating and a $117.00 price objective on the stock. Citigroup upgraded shares of Clorox from a “neutral” rating to a “buy” rating and raised their target price for the company from $135.00 to $150.00 in a research note on Thursday, November 2nd. Raymond James cut shares of Clorox from an “outperform” rating to a “market perform” rating in a research report on Thursday, October 5th. Finally, StockNews.com upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research note on Thursday, December 7th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Clorox presently has an average rating of “Hold” and an average target price of $142.13.

Get Our Latest Stock Report on CLX

Clorox Stock Performance

Shares of NYSE CLX traded up $0.67 during trading on Friday, reaching $144.82. 565,066 shares of the stock traded hands, compared to its average volume of 1,155,444. The company has a 50-day moving average of $142.15 and a 200-day moving average of $142.24. The stock has a market capitalization of $17.97 billion, a P/E ratio of 212.44, a price-to-earnings-growth ratio of 2.93 and a beta of 0.41. The company has a debt-to-equity ratio of 18.92, a current ratio of 0.86 and a quick ratio of 0.54. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $178.21.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Wednesday, November 1st. The company reported $0.49 EPS for the quarter, beating the consensus estimate of ($0.20) by $0.69. Clorox had a return on equity of 195.76% and a net margin of 1.22%. The firm had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.31 billion. During the same period in the prior year, the company earned $0.93 EPS. The company’s revenue was down 20.3% on a year-over-year basis. Analysts forecast that The Clorox Company will post 4.57 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be given a dividend of $1.20 per share. This represents a $4.80 dividend on an annualized basis and a yield of 3.31%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox’s dividend payout ratio (DPR) is presently 705.89%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.